COCP Selection for Patients on Klonopin and Adderall

No Drug Interactions Present

• The Centers for Disease Control and Prevention recommends that any standard low-dose combined oral contraceptive pill can be safely used in patients taking clonazepam and amphetamine/dextroamphetamine, as neither medication has clinically significant interactions with hormonal contraceptives 1
• Enzyme inducers, such as phenytoin and carbamazepine, decrease COCP effectiveness, but clonazepam and Adderall do not fall into this category 1

Recommended COCP Formulations

• The American Academy of Pediatrics recommends starting with a low-dose monophasic pill containing 30-35 mcg ethinyl estradiol combined with levonorgestrel or norgestimate, which are first-line options with well-established safety profiles 2
• These formulations are associated with lower VTE risk compared to newer progestins, with a typical-use failure rate of 9% 2
• Alternative acceptable formulations include any "low-dose" pill (≤35 mcg ethinyl estradiol) 2

Initiation Protocol

• The Centers for Disease Control and Prevention recommends using the quick-start method, starting COCP on the same day as the visit if reasonably certain the patient is not pregnant 1
• If started within 5 days of menstrual bleeding onset, no backup contraception is needed, but if started >5 days after menses, use backup contraception for 7 consecutive days 1
• Blood pressure measurement is required before initiation, but no pelvic examination is needed 1

Important Counseling Points

• The American Academy of Pediatrics recommends addressing adherence strategies, such as taking the pill at the same time daily and using cell phone alarms or other reminders, since typical-use failure is significantly higher than perfect-use failure 4
• If one pill is missed, take it as soon as remembered, and if ≥2 pills are missed, take the most recent missed pill, discard others, and use backup contraception for 7 days 3
• Condoms should be used consistently for STI protection regardless of COCP use 2

Common Pitfalls to Avoid

• The Centers for Disease Control and Prevention recommends not avoiding COCPs due to concerns about psychotropic medication interactions, as SSRIs and benzodiazepines have no contraindications with COCPs 1
• The American Academy of Pediatrics recommends not prescribing higher-dose pills unnecessarily, as the lowest effective dose minimizes VTE risk 2

Follow-Up

• The American Academy of Pediatrics recommends scheduling routine follow-up at 1-3 months after initiation to address any adverse effects or adherence issues, and considering prescribing up to 1 year supply at a time to improve continuation rates 2